Arthur Santora MD
Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid
Clinical Associate Professor
Join to View Full Profile
125 Paterson StClinical Academic Building - Suite 5200aNew Brunswick, NJ 08901
Phone+1 732-235-7219
Dr. Santora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Arthur Santora, MD, is an accomplished endocrinologist based in New Brunswick, NJ. He holds subspecialties in Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, and Parathyroid disorders. He attended Emory University School of Medicine and completed his residency and fellowship there and at the National Institutes of Health Clinical Center. Dr. Santora has a rich career history including roles as Chief Medical Officer at EnteraBio LTD, Consultant at Kinexum LLC, and Associate VP of Clinical Research at Merck. He has significant experience with hypocalcemia, hypercalcemia, hypophosphatemia, lipid metabolism disorders and osteoporosis. He is also an established author with multiple publications in respected journals. Dr. Santora has been recognized with the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services and as a Fellow by the American Association of Clinical Endocrinology.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1984
Emory University School of MedicineResidency, Internal Medicine, 1978 - 1981- Emory University School of MedicineClass of 1978
Certifications & Licensure
NJ State Medical License 1989 - 2025
MI State Medical License 1986 - 2020
GA State Medical License 1980 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 3 citationsOral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study.Liana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, Vanessa Rouach, Chana Sternberg
Journal of Bone and Mineral Research. 2024-07-23 - 13 citationsIncidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture TrialSocrates E. Papapoulos, Henry G. Bone, Felicia Cosman, David W. Dempster, Michael R. McClung
Journal of Bone and Mineral Research. 2021-04-27 - 2 citationsEarly changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysisKenneth G. Saag, Felicia Cosman, T. J. de Villiers, Bente L. Langdahl, Boyd B. Scott
Osteoporosis International. 2021-02-19
Journal Articles
- Open-Label Study of Treatment with Alendronate Sodium plus Vitamin D in Men and Women with Osteoporosis in ThailandArthur Santora, MD, BioMed Central
Press Mentions
Chutes & Ladders—Curis Moves up COO as CEO Fattaey DepartsSeptember 28th, 2018- Former Merck Clinical Research VP Arthur Santora Joins Entera Bio as CMOSeptember 24th, 2018
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenMarch 18th, 2004
Professional Memberships
- American Society for Bone and Mineral ResearchMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
